Korea News
-
SK bioscience reaches final stage of developing Korea´s first COVID-19 vaccine
Korea | News | 0 Comment | 02 May, 2022
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...Read more
-
South Korean firms lay focus on immune cell therapy
Korea | News | 0 Comment | 29 Apr, 2022
Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...Read more
-
Korean firm GC Biopharma explores use of lipid nanoparticle delivery system in mRNA vaccines
Korea | News | 0 Comment | 28 Apr, 2022
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...Read more
-
Korea | News | 0 Comment | 27 Apr, 2022
Korea's PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next-generation antibody thera...Read more
-
Korea's Seegene unveils world's first commercialised '3 Ct' PCR assay
Korea | News | 0 Comment | 27 Apr, 2022
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has announced the development of the ...Read more
-
Adge Pharma, Cyan Bio advance treatments for rare paediatric diseases in Asian countries
Korea | News | 0 Comment | 26 Apr, 2022
Adge Pharmaceuticals has entered into a license agreement with South Korea-based Cyan Bio, Inc. Cyan will receive exclus...Read more
-
Korean firm Vuno partners with Mayo Clinic for AI-based precision oncology
Korea | News | 0 Comment | 25 Apr, 2022
South Korea-based startup Vuno has signed a research agreement with Mayo Clinic in the US. The research agreement, which...Read more
-
Korea develops COVID-19 detection platform by 'slowing down light'
Korea | News | 0 Comment | 22 Apr, 2022
A research group led by Professor Young Min Song of the Gwangju Institute of Science and Technology in Korea h...Read more
-
Korea's LG Chem pushes targeting of global atopic dermatitis market worth KRW 29 trillion
Korea | News | 0 Comment | 21 Apr, 2022
South Korea's LG Chem has announced that its Chinese counterpart TransThera Sciences received the IND clearance fro...Read more
-
Korean firm GC buys US-based CDMO BioCentriq to enhance global capabilities
Korea | News | 0 Comment | 20 Apr, 2022
GC corp., the holding (system) company for GC group in South Korea with major operating companies across healthcare se...Read more
-
GeneQuantum and AIMEDBIO collaborate on a first-in-class antibody drug conjugate
Korea | News | 0 Comment | 19 Apr, 2022
China's GeneQuantum Healthcare, a company specializing in site-specific bioconjugation for next generation biotherapeuti...Read more
-
Korea's Bridge Biotherapeutics to enhance solutions for idiopathic pulmonary fibrosis
Korea | News | 0 Comment | 19 Apr, 2022
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...Read more
-
Korea puts focus on AI-powered analytic tool for lung cancer immunotherapy
Korea | News | 0 Comment | 18 Apr, 2022
Professor Tony MOK Shu Kam from The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) has...Read more
-
CytoReason expands reach in Asia, leveraging ML in drug development for Korean drugmakers
Korea | News | 0 Comment | 13 Apr, 2022
Israel's CytoReason, a leading developer of computational disease models for efficient drug discovery and developme...Read more
-
Korean firms back US-based Turn Bio for mRNA therapies
Korea | News | 0 Comment | 12 Apr, 2022
South Korea-based Daewoong Pharmaceutical and HanAll Biopharma have announced expansion of their open collabo...Read more
-
Korea's OliX Pharmaceuticals identifies target genes for NASH treatment candidate
Korea | News | 0 Comment | 11 Apr, 2022
Korea's OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has identified effective inhibition o...Read more
-
Korea promotes vaccine development & delivery, bio-manufacturing training for LMICs
Korea | News | 0 Comment | 08 Apr, 2022
The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed ...Read more
-
MolecuLight i:X receives regulatory clearance and reimbursement in South Korea
Korea | News | 0 Comment | 07 Apr, 2022
MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated...Read more
